Stryker Acquires Artelon

June 3, 2024

Stryker has signed a definitive agreement to acquire all issued and outstanding shares of Artelon, a privately held developer of soft tissue fixation products for foot & ankle and sports medicine procedures. The deal adds Artelon's synthetic biomaterial technology and product portfolio (with over 60,000 implantations worldwide) to Stryker's foot & ankle and sports medicine offerings and is subject to customary closing conditions.

Buyers
Stryker
Targets
Artelon
Industry
Medical Devices
Location
Georgia, United States
Transaction Type
Buyout

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.